ERBB2 and breast carcinoma: Database analyses have suggested that CI functionality is related to poor prognosis in patients with cancer, specifically with the hormone receptor (HR)(+)/human epidermal growth factor receptor 2 (HER2)(−) subtype of breast cancer.